The use of gelclari in the treatment of pain from chemotherapy induced stomatitis in patients with hematologic malignancies.

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/046/30/06

Funding

  • OSI Pharmaceuticals: $7,502.00